A nationwide shortage of baby formula was caused by the restart of production at the Sturgis, Michigan baby formula factory.
Abbott said that they would ramp production as quickly as possible. We will do everything we can to regain the trust parents, caregivers and health care providers have placed in us.
Two infants died after consuming formula products manufactured at the Abbott Nutrition plant. Cronobacter sakazakii was linked to the illnesses.
According to Insider's Sam Tabahriti, Abbott said it would prioritize the production of its EleCare specialty formulas for infants with allergies. The company said it is working hard to fulfill the steps necessary to restart production and will do so as soon as possible.
It will take three weeks for Abbott's products to hit store shelves. In May, the company reached a deal with the FDA, agreeing to an FDA inspection at the Sturgis plant and Abbott bringing in outside help to reopen it.
The Federal Trade Commission was directed by the Biden administration to crack down on profiteering when it came to baby formula in May.
An Abbott spokesman said the company was shipping in products and offering deep discounts.
The cans of infant formula were flown into the US from Ireland. The Columbus, Ohio, facility is the priority for infant formula production.
"Our other manufacturing facilities are at full capacity as we continue to prioritize production of infant formula to help replenish the supply in the market," the spokesman said.
The plant had a leaking roof, broken equipment, and unsanitary surfaces according to the FDA. The FDA was unable to link the infections in the infants to the plant because it was unsanitary.